107 related articles for article (PubMed ID: 26498213)
1. Gastrointestinal comorbidities in patients with psoriasis in the Czech Republic: The results of 189 patients with psoriasis and 378 controls.
Juzlova K; Votrubova J; Dzambova M; Gopfertova D; Hercogova J; Smerhovsky Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):100-5. PubMed ID: 26498213
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for comorbidities in Czech psoriatic patients: results of a hospital-based case-control study.
Votrubova J; Juzlova K; Smerhovsky Z; Fialova J; Gopfertova D; Vojackova N; Hercogova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Jun; 158(2):288-94. PubMed ID: 24077232
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis, the liver, and the gastrointestinal tract.
Gisondi P; Del Giglio M; Cozzi A; Girolomoni G
Dermatol Ther; 2010; 23(2):155-9. PubMed ID: 20415823
[TBL] [Abstract][Full Text] [Related]
4. [Coexistence of coeliac disease and inflammatory bowel disease in children].
Krawiec P; Pawłowska-Kamieniak A; Pac-Kożuchowska E; Mroczkowska-Juchkiewcz A; Kominek K
Pol Merkur Lekarski; 2016 Jan; 40(235):53-5. PubMed ID: 26891438
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis associated with ulcerative colitis and Crohn's disease.
Cohen AD; Dreiher J; Birkenfeld S
J Eur Acad Dermatol Venereol; 2009 May; 23(5):561-5. PubMed ID: 19207663
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of inflammatory bowel disease among coeliac disease patients in a Hungarian coeliac centre.
Kocsis D; Tóth Z; Csontos ÁA; Miheller P; Pák P; Herszényi L; Tóth M; Tulassay Z; Juhász M
BMC Gastroenterol; 2015 Oct; 15():141. PubMed ID: 26481725
[TBL] [Abstract][Full Text] [Related]
7. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of serological tests in the diagnosis of celiac disease].
Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
Kull K; Salupere R; Uibo R; Ots M; Salupere V
Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
[TBL] [Abstract][Full Text] [Related]
11. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence.
Di Tola M; Sabbatella L; Anania MC; Viscido A; Caprilli R; Pica R; Paoluzi P; Picarelli A
Clin Chem Lab Med; 2004; 42(10):1092-7. PubMed ID: 15552265
[TBL] [Abstract][Full Text] [Related]
12. [Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease].
Malícková K; Janatková I; Fucíková T; Adamec S; Lukás M
Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):131-5. PubMed ID: 11550421
[TBL] [Abstract][Full Text] [Related]
13. Human recombinant anti-transglutaminase antibody testing is useful in the diagnosis of silent coeliac disease in a selected group of at-risk patients.
Vivas S; Ruiz de Morales JM; Martinez J; González MC; Martín S; Martín J; Cechini C; Olcoz JL
Eur J Gastroenterol Hepatol; 2003 May; 15(5):479-83. PubMed ID: 12702903
[TBL] [Abstract][Full Text] [Related]
14. [Chronic inflammatory bowel disease and cardiovascular complications].
Rellecke P; Strauer BE
Med Klin (Munich); 2006 Mar; 101 Suppl 1():56-60. PubMed ID: 16802521
[TBL] [Abstract][Full Text] [Related]
15. [Significance of serum antibodies ANCA, ASCA, ABBA in diagnostics of idiopathic intestinal inflammations].
Pintér M; Pintérová KM; Drahosová M; Rejchrt S; Douda T; Tachecí I; Kopácová M; Bures J
Cas Lek Cesk; 2007; 146(11):863-7. PubMed ID: 18069213
[TBL] [Abstract][Full Text] [Related]
16. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease].
Lecis P; Germanà B; Papa N; Bertiato G; Doglioni C; Galliani E; Biedo FC
Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913
[TBL] [Abstract][Full Text] [Related]
17. The association of autoimmune disorders with inflammatory bowel disease.
Snook JA; de Silva HJ; Jewell DP
Q J Med; 1989 Sep; 72(269):835-40. PubMed ID: 2616728
[TBL] [Abstract][Full Text] [Related]
18. Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn's disease: a general population-based study.
West J; Logan RF; Hubbard RB; Card TR
Aliment Pharmacol Ther; 2006 Jan; 23(1):71-4. PubMed ID: 16393282
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease.
Papo M; Quer JC; Pastor RM; García-Pardo G; Prats E; Mirapeix E; Rodríguez R; Richart C
Am J Gastroenterol; 1996 Aug; 91(8):1512-5. PubMed ID: 8759652
[TBL] [Abstract][Full Text] [Related]
20. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease.
Mahler M; Bogdanos DP; Pavlidis P; Fritzler MJ; Csernok E; Damoiseaux J; Bentow C; Shums Z; Forbes A; Norman GL
Clin Chim Acta; 2013 Sep; 424():267-73. PubMed ID: 23806819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
